Eggebrecht, Lisa
Bauerfeind, Anja
Boehnke, Tanja
Rizzo, Manuel
Hagemann, Christine
Lange, Jens
Viet, Mareike
Pauls, Karl
von Stockum, Sophia
Klinghardt, Moritz
Heinemann, Klaas
Article History
Received: 23 August 2024
Accepted: 28 February 2025
First Online: 14 March 2025
Declarations
:
: EURAS-LCS12 was approved by the relevant Independent Ethics Committee (IEC)/Institutional Review Board (IRB) and was conducted in compliance with the IEC/IRB, informed consent regulations, the declaration of Helsinki [], and the Good Epidemiological Practice (GEP)/ Good pharmacovigilance practices (GVP)/ Good Pharmacoepidemiology Practice (GPP) guidelines []. Written informed consent for use of a participant’s sensitive data was obtained from the participant, or their legally acceptable representative, before entry into the study.
: Not applicable.
: The authors declare no competing interests.